{
    "clinical_study": {
        "@rank": "31987", 
        "acronym": "RAPIDA", 
        "arm_group": {
            "arm_group_label": "Arm 1", 
            "arm_group_type": "Experimental", 
            "description": "Adalimumab"
        }, 
        "brief_summary": {
            "textblock": "Rapidity of response to treatments in inflammatory bowel diseases is now considered a field\n      of major interest, due to the importance of achieving the highest benefit in the shortest\n      possible time, in order to favor a fast backward step to normal life. There are no previous\n      studies specifically designed to evaluate the rapidity of response to adalimumab therapy in\n      patients with active Crohn's disease. Studies on rapidity of onset of response to adalimumab\n      have, on the other hand, been performed in other diseases such as rheumatoid arthritis\n      (Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis HERO study, Wolfe et al,\n      2006). This trial will assess the clinical responses occurring earlier than in week 1. This\n      is an open label, one arm, prospective, multicenter, phase IV clinical trial."
        }, 
        "brief_title": "Rapidity of Response to Adalimumab Treatment in Patients With Crohn\u00b4s Disease", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Moderate to Severe Crohn's Disease", 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Crohn's disease diagnosed within, at least, the previous 4 months.\n\n          -  Patients with active luminal (Harvey-Bradshaw Index \u22658) moderate to- severe Crohn\u00b4s\n             disease.\n\n          -  No response to a full and adequate course of therapy with a corticosteroid and/or an\n             immunosuppressant.\n\n          -  If receiving any of the following treatments, their dose should be stable during the\n             periods indicated:\n\n               1. Amino salicylates for, at least, the last 4 weeks\n\n               2. Probiotics for, at least, the last 4 weeks\n\n               3. Analgesics for, at least, the last 4 weeks\n\n               4. Anti-diarrheal' s for, at least, the last 4 weeks\n\n               5. Oral budesonide (maximum dose of 9 mg/day) for, at least, the last 2 weeks\n\n               6. Oral prednisone or equivalent for, at least, the last 2 weeks\n\n               7. Crohn's disease -related antibiotics for, at least, the last 4 weeks\n\n               8. Azathioprine, 6-mercaptopurine or methotrexate for, at least, the last 12 weeks\n\n        Exclusion Criteria:\n\n          -  Previous treatment with any anti-Tumor Necrosis Factor agent.\n\n          -  Surgical bowel resection within the previous 6 months, ostomy, extensive bowel\n             resection (> 100 cm), short bowel syndrome, Fistulising Crohn's disease.\n\n          -  Treatment with cyclosporine or tacrolimus within the previous 8 weeks.\n\n          -  Clinically significant cardiac disease including unstable angina, acute myocardial\n             infarction within six months from screening, congestive heart failure of worse than\n             grade II New York criteria (New York Heart Association Functional Classification).\n\n          -  Subject with an ostomy or ileoanal pouch, proctocolectomy, total colectomy,\n             ileostomy, stoma or ileal pouchanal anastomosis (Subjects with a previous ileo-rectal\n             anastomosis are not excluded).\n\n          -  Screening laboratory values (according to central laboratory)\n\n          -  Known of hepatitis C (HC) infection.\n\n          -  Serologic evidence of hepatitis B (HB) infection based on the results of testing for\n             hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc) and\n             hepatitis B surface antibody (anti-HBs) antibodies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "98", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02148718", 
            "org_study_id": "W13-984", 
            "secondary_id": "2013-004781-34"
        }, 
        "intervention": {
            "arm_group_label": "Arm 1", 
            "description": "ADALIMUMAB", 
            "intervention_name": "ADALIMUMAB", 
            "intervention_type": "Biological", 
            "other_name": "Humira, ABT-D2E7"
        }, 
        "intervention_browse": {
            "mesh_term": "Adalimumab"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Crohn's Disease", 
        "lastchanged_date": "May 23, 2014", 
        "link": {
            "description": "This clinical study is evaluating the drug Humira. Please see prescribing information uses in this link.", 
            "url": "http://rxabbvie.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain", 
                        "zip": "03010"
                    }, 
                    "name": "Site Reference ID/Investigator# 125655"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125655", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08041"
                    }, 
                    "name": "Site Reference ID/Investigator# 125657"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125657", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelono", 
                        "country": "Spain", 
                        "zip": "08221"
                    }, 
                    "name": "Site Reference ID/Investigator# 125659"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125659", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ciudad Real", 
                        "country": "Spain", 
                        "zip": "13005"
                    }, 
                    "name": "Site Reference ID/Investigator# 124197"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124197", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }, 
                    "name": "Site Reference ID/Investigator# 125683"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125683", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ferrol", 
                        "country": "Spain", 
                        "zip": "15402"
                    }, 
                    "name": "Site Reference ID/Investigator# 125685"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125685", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gerona", 
                        "country": "Spain", 
                        "zip": "17007"
                    }, 
                    "name": "Site Reference ID/Investigator# 125916"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125916", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leon", 
                        "country": "Spain", 
                        "zip": "24701"
                    }, 
                    "name": "Site Reference ID/Investigator# 125675"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125675", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Site Reference ID/Investigator# 125676"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125676", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Site Reference ID/Investigator# 125686"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125686", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Site Reference ID/Investigator# 125677"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125677", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28009"
                    }, 
                    "name": "Site Reference ID/Investigator# 125678"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125678", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "13007"
                    }, 
                    "name": "Site Reference ID/Investigator# 124200"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124200", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Navarra", 
                        "country": "Spain", 
                        "zip": "31008"
                    }, 
                    "name": "Site Reference ID/Investigator# 125679"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125679", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "zip": "31008"
                    }, 
                    "name": "Site Reference ID/Investigator# 124199"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sant Joan Despi (Barcelona)", 
                        "country": "Spain", 
                        "zip": "08970"
                    }, 
                    "name": "Site Reference ID/Investigator# 124196"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 124196", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago de Compostela", 
                        "country": "Spain", 
                        "zip": "15706"
                    }, 
                    "name": "Site Reference ID/Investigator# 125661"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125661", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Site Reference ID/Investigator# 125681"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125681", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seville", 
                        "country": "Spain", 
                        "zip": "41009"
                    }, 
                    "name": "Site Reference ID/Investigator# 125682"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125682", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46014"
                    }, 
                    "name": "Site Reference ID/Investigator# 125656"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 125656", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "1", 
        "official_title": "Rapidity of Onset of Response to Adalimumab in Luminal Crohn's Disease (RAPIDA Study)", 
        "overall_contact": {
            "email": "lucia.rodriguezsanpedro@abbvie.com", 
            "last_name": "Luc\u00eda  Rodriguez San Pedro", 
            "phone": "+34.91.334.40.92 Extn: 3092"
        }, 
        "overall_contact_backup": {
            "email": "rocio.casado@abbvie.com", 
            "last_name": "Rocio   Casado", 
            "phone": "+34.91.337.52.85 Extn: 5285"
        }, 
        "overall_official": {
            "affiliation": "Hospital General Universitario Gregorio Mara\u00f1on", 
            "last_name": "Ignacio  Mar\u00edn, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical response is defined as a decrease of at least 3 points in the Harvey-Bradshaw Index.", 
            "measure": "Proportion of patients with clinical response", 
            "safety_issue": "No", 
            "time_frame": "Up to Week 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02148718"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Clinical remission is defined as Harvey- Bradshaw Index <5.", 
                "measure": "Proportion of patients with clinical remission", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 4"
            }, 
            {
                "description": "This is used to assess the quality of life.", 
                "measure": "Change in EuroQOL five dimensions (EQ-5D) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "From Week 1 to Week 12"
            }, 
            {
                "description": "It is assessed through the Fatigue Impact Scale for Daily Use (D-FIS).", 
                "measure": "Change in Fatigue", 
                "safety_issue": "No", 
                "time_frame": "From Week 1 to Week 12"
            }, 
            {
                "description": "Analytic markers include hemogram, erythrocytes sedimentation rate (ESR), C-reactive protein (CRP), fecal calprotectin and coagulation (including fibrinogen).", 
                "measure": "Change in analytic markers of inflammation", 
                "safety_issue": "No", 
                "time_frame": "From Week 1 to Week 12"
            }, 
            {
                "description": "Statistical analysis will be performed to evaluate the correlation between a clinical response at day 4 and week 1 with remission at week 12", 
                "measure": "Correlation between Clinical response and remission", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 12"
            }, 
            {
                "description": "This is used to assess the quality of life.", 
                "measure": "Change in Inflammatory Bowel Disease Questionnaire-36 (IBDQ36) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "From Week 1 to Week 12"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Pivotal S.L.", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Laboratorio Echevarne", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "AbbVie", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}